Global Heart Attack Diagnostic market growth 2024, Forecast To 2033
4 Mar, 2024
The heart attack diagnostic market has witnessed robust growth, ascending from$10.21 billion in 2023 to$11.07 billion in 2024, with a compound annual growth rate (CAGR) of 8.5%. This growth is attributed to the development of cardiac biomarkers, the introduction of electrocardiogram (ECG) and imaging techniques, standardization of diagnostic protocols, awareness and educational initiatives, and enhancements in troponin testing. Forecasts suggest continued strong growth, with the market expected to reach$15.26 billion by 2028, exhibiting a compound annual growth rate (CAGR) of 8.3%. Factors driving this growth include patient empowerment and engagement, data analytics and precision medicine applications, preventive healthcare initiatives, healthcare infrastructure development, and personalized diagnostic approaches. Major trends in the forecast period include point-of-care testing, high-sensitivity troponin tests, non-invasive imaging techniques, personalized medicine, and remote monitoring devices.
Global Heart Attack Diagnostic Market Key Driver
The heart attack diagnostics market is experiencing substantial growth, propelled by the rising prevalence of cardiac disorders globally. Cardiovascular diseases (CVDs) claim 17.9 million lives annually, with heart attacks and strokes accounting for a significant portion, as reported by the World Health Organization. With CVDs accounting for one-third of global deaths, there's an escalating need for advanced diagnostic tools to analyze and address cardiac conditions effectively. This persistent rise in cardiovascular illnesses is anticipated to drive the heart attack diagnostics market forward in 2023, 2024, and 2028.
Get A Free Sample Of The Global Heart Attack Diagnostic Market ReportGlobal Heart Attack Diagnostic Market Segments
The global heart attack diagnostic market covered in this report is segmented –
1) By Test Type: Electrocardiogram (ECG/EKG), Blood Tests, X-Ray, Echocardiogram, Coronary Catheterization (Angiogram), Exercise Stress Test, Magnetic Resonance Imaging (MRI)
2) By Procedure: Invasive Procedure, Non-Invasive Procedure
3) By End-Use Industry: Hospitals, Ambulatory Surgical Centers, Diagnostics Centers, Other End-Users
By Geography: The regions covered in the heart attack diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa.
North America was the largest region in the heart attack diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart attack diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major Heart Attack Diagnostic Industry Players
Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Co., Hitachi Ltd., Koninklijke Philips NV, Midmark Corp., Siemens AG, Toshiba Corp., Welch Allyn Inc., Astrazenca PLC., HILL ROM HOLDINGS Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., Fujifilm Holdings, ACS Diagnostics Inc., Beckman Coulter Inc., Schiller AG, GE Healthcare, HeartFlow, Medtronic PLC, Cardio Diagnostics Holdings Inc., Beckman Coulter Inc., Becton Dickinson and Company, Danaher Corporation, Edwards Lifesciences Corporation, Illumina Inc., Johnson & Johnson, Merck & Co. Inc., Novartis International AG, Pfizer Inc., Quest Diagnostics, Roche Diagnostics, Thermo Fisher Scientific Inc.
Get The Full Global Heart Attack Diagnostic Market Report
Heart Attack Diagnostic Market Overview
Heart attack diagnostics are defined as the methods of identification, monitoring, screening, and prognosis that help validate the heart attack's diagnosis, as well as help, determine the type of heart attack a patient has had, which will help determine the most effective treatment. Heart attack diagnostics are used to diagnose heart disease.
Heart Attack Diagnostic Global Market Report 2023 provides data on the global heart attack diagnostic market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The heart attack diagnostic market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.